OM: if PS is small, add diluent and use blend style Final Formulation: calculate capsule size, % excipients, and final formulation DF: choose excipients.

Slides:



Advertisements
Similar presentations
 AUTHOR- Musiba Baliruno Denis, B.pharm (MUST) SUPERVISORS ;  Prof. K.A.M. Kuria, PhD - Department of Pharmaceutics and Pharmacy Practice, University.
Advertisements

Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines / October |1 | Training Workshop on Pharmaceutical Development.
Statistical Approaches to Addressing the Requirements of the New FDA Process Validation Guidance for Small Molecules 1 Jason Marlin, MS/T Statistics, Eli.
The Gamlen Tablet Press (GTP) Michael Gamlen Gamlen Tableting Ltd.
By Timina Olive Kayaviri Supervisor : Dr. Amugune
L OUISIANA T ECH U NIVERSITY Department of Electrical Engineering and Institute for Micromanufacturing INTRODUCTION PROBLEM FORMULATION STATE FEEDBACK.
U D A Neural Network Approach for Diagnosis in a Continuous Pulp Digester Pascal Dufour, Sharad Bhartiya, Prasad S. Dhurjati, Francis J. Doyle III Department.
Institute of Intelligent Power Electronics – IPE Page1 Introduction to Basics of Genetic Algorithms Docent Xiao-Zhi Gao Department of Electrical Engineering.
4-1 Management Information Systems for the Information Age Copyright 2002 The McGraw-Hill Companies, Inc. All rights reserved Chapter 4 Decision Support.
Supervised classification performance (prediction) assessment Dr. Huiru Zheng Dr. Franscisco Azuaje School of Computing and Mathematics Faculty of Engineering.
Lazy Learning k-Nearest Neighbour Motivation: availability of large amounts of processing power improves our ability to tune k-NN classifiers.
Learning Object Identification Rules for Information Integration Sheila Tejada Craig A. Knobleock Steven University of Southern California.
1 Chapter 4 Decision Support and Artificial Intelligence Brainpower for Your Business.
Planning operation start times for the manufacture of capital products with uncertain processing times and resource constraints D.P. Song, Dr. C.Hicks.
Abwova Veronica Vugutsa B. Pharm
C h a p t e r PART TWO - STAFFING THE ORGANIZATION Selecting Employees 8.
SIMULATION. Simulation Definition of Simulation Simulation Methodology Proposing a New Experiment Considerations When Using Computer Models Types of Simulations.
Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science, CDER, FDA An Example of Process Understanding Directed Risk Based CMC Regulatory.
World Health Organization
Multi station rotary presses
Next Generation Techniques: Trees, Network and Rules
NATIONAL INSTITUTE OF SCIENCE & TECHNOLOGY Presented by:Manoj Kumar Gantayat CS: Technical Seminar Presentation by MANOJ KUMAR GANTAYAT.
DOE – An Effective Tool for Experimental Research
Introduction to Computer Aided Process Planning
Chapter 6 System Engineering - Computer-based system - System engineering process - “Business process” engineering - Product engineering (Source: Pressman,
Comparing the Parallel Automatic Composition of Inductive Applications with Stacking Methods Hidenao Abe & Takahira Yamaguchi Shizuoka University, JAPAN.
Crowdsourcing Predictors of Behavioral Outcomes. Abstract Generating models from large data sets—and deter¬mining which subsets of data to mine—is becoming.
University of Medicine and Pharmacy „Iuliu Haţieganu”, Faculty of Pharmacy Department of Pharmaceutical Technology and Biopharmaceutics, , Cluj-Napoca,
Quality by Design Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants.
Joint tracking in friction stir welding Paul Fleming Vanderbilt University Welding Automation Laboratory.
Title: Plan for Approach to the Understanding and Predicting Excipient Properties and Functionality NIPTE - National Institute of Pharmaceutical Technology.
Module 1, Part 3: Process validation Slide 1 of 22 © WHO – EDM – 12/2001 Validation Part 3: Process validation Supplementary Training Modules on Good Manufacturing.
PHARMACEUTICS- IV (PHT 414 ) Dr. Shahid Jamil SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L /9/2015 Factors Affecting Drug Absorption (Dosage.
NEURAL NETWORKS FOR DATA MINING
Department of Electrical Engineering, Southern Taiwan University Robotic Interaction Learning Lab 1 The optimization of the application of fuzzy ant colony.
Novel Multifunctional Excipients by Co-processing with Mg-Silicate Dr. Faisal Al-Akayleh Faculty of Pharmacy, Petra University.
<701> DISINTEGRATION
Critical Material Properties for Pharmaceutical Dosage Forms - Industry Perspective Tony Hlinak Abbott Laboratories North Chicago, IL.
McGraw-Hill/Irwin © 2006 The McGraw-Hill Companies, Inc., All Rights Reserved. 1.
Satish Mallya January 20-22, |1 | 2-3. Pharmaceutical Development Satish Mallya Quality Workshop, Copenhagen May 18-21, 2014 May 18-21,2014.
Blend Uniformity: Update Ajaz S. Hussain, Ph.D.. Background Issue: Assuring and documenting “adequacy of mixing” operations –PQRI’s Proposal Stratified.
Chapter 8: Adaptive Networks
Hazırlayan NEURAL NETWORKS Backpropagation Network PROF. DR. YUSUF OYSAL.
Tablet Granulation. Introduction  Granulation is the process in which primary powder particles are made to adhere to form larger, multi particle entities.
Advanced elements for transforming networks. VLADISLAV SKORPIL Department of Telekommunications, Brno University of Technology, Purkynova 118,
The article written by Boyarshinova Vera Scientific adviser: Eltyshev Denis THE USE OF NEURO-FUZZY MODELS FOR INTEGRATED ASSESSMENT OF THE CONDITIONS OF.
A Decision Support Based on Data Mining in e-Banking Irina Ionita Liviu Ionita Department of Informatics University Petroleum-Gas of Ploiesti.
Introduction to Computer Aided Process Planning
Chapter 11 – Neural Nets © Galit Shmueli and Peter Bruce 2010 Data Mining for Business Intelligence Shmueli, Patel & Bruce.
Precise Calibration: Remote Center of Motion Robot Computer Integrated Surgery II - Spring, 2011 Ryan Decker, Changhan Jun, Alex Vacharat, under Professor.
Integration of Excipients into the Design of Experiments for Pharmaceutical Product and Design Space Development Chris Moreton, Ph.D. FinnBrit Consulting.
Faculty of Pharmacy and Medical Sciences Al-Ahliyya Amman University
Results and Discussion
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
OPERATIONS RESEARCH.
Enabling direct compaction at high drug loading via dry coating of APIs: Towards a predictive framework Presenter(s): Kuriakose T. Kunnath, NJIT Research.
An Artificial Intelligence Approach to Precision Oncology
,Branko Vranic1, Nada Tarek2 ,V. Frost 3, G. Betz1
Gastrointestinal Absorption: Role of the Dosage Form
BTEC Applied science The applied science btec qualification is an excellent choice for those who need 2 science qualifications without the exam stress.
A Practical Framework Toward Prediction of Breaking Force and Disintegration of Tablet Formulations Using Machine Learning Tools  Ilgaz Akseli, Jingjin.
Office of Pharmaceutical Science, CDER, FDA
J.Preethi*, P. Madhu, K. Arshad Ahmed Khan.
Tablet Dosage Form Lab 1.
Deep Learning for the Soft Cutoff Problem
Application of artificial neural network in materials research
Formulation factors By Dr. A. S. Adebayo.
University of sulaimani
2019/9/14 The Deep Learning Vision for Heterogeneous Network Traffic Control Proposal, Challenges, and Future Perspective Author: Nei Kato, Zubair Md.
Primer on Neural networks
Presentation transcript:

OM: if PS is small, add diluent and use blend style Final Formulation: calculate capsule size, % excipients, and final formulation DF: choose excipients types CU: calculate PS to meet content- uniformity limit GUI: interfaceC functions BCS II Y MES Prediction Control ANN User: Acceptable? Final formulation Parameter Adjustment Reformulate YN Predicted dissolution rate for the current formulation CAPEX Prolog Engine compute result N Prediction Engine A Hybrid Expert System-Neural Network (“Expert Network”) for Capsule Formulation Support 1 Gunjan Kalra, 2 Mintong Guo, 1 Yun Peng, 2 Larry L. Augsburger University of Maryland, Department of Computer Science and Electrical Engineer, Baltimore County; 2 University of Maryland, School of Pharmacy, Baltimore The objective was to construct a prototype intelligent hybrid Prototype Expert Network (PEN) for capsule formulation, which may yield formulations meeting specific running and drug delivery performance design criteria for BCS II drugs. To that end, a rule-based expert system (MES) was developed to specifically address BCS Class II drugs and integrated with a neural network (NN). These two components, which comprise the decision module and the prediction module, respectively, are connected together by two information exchange paths to form a loop. The system is believed to have the power to design a suitable capsule formulation to meet both requirements of quality control and dissolution. Introduction Microcrystalline cellulose (Avicel PH102 (FMC), Emcocel 90M (Penwest)), anhydrous lactose (direct tableting grade, Quest International), piroxicam (donated from Pfizer), magnesium stearate, Explotab (Penwest), Ac-Di-Sol ( FMC) and sodium lauryl sulfate have been used in the study. An instrumented Zanasi LZ-64 was used for the encapsulation process, and the compression force was maintained at 100 ~ 200N to achieve the specific target weight. The plug height was adjusted at 14mm. The dissolution testing was conducted on a Vankel 5000 dissolution station, and followed the USP procedure. The percentage dissolved in 10, 30 and 45 minutes were recorded as the measurements for the dissolution rate. Sixty-three batches have been generated to train and validate the system. A rule-based expert system was developed in Prolog by followed the decision procedures in the flow chat, and integrated with a neural network (NN). These two components, which comprise the decision module and the prediction module, respectively, are connected together by two information exchange paths to form a loop. Materials and Method Results and Discussion Conclusion Training Data Set Acknowledgement This work is being supported by Capsugel. We also gratefully acknowledge Pfizer Central Research for the gift of piroxicam. An expert system (MES) in the decision module (based on a decision tree modeled after the Capsugel Expert System 1 [CAPEX]) was developed to provide decision rules for formulation recommendation. The NN in the prediction module (using backpropagation learning) was developed to provide predictive capability for the expected outcomes of the recommended formulation. The NN was trained with experiment data to capture the causal associations between the formulation and the outcome. The training was conducted with two experimental datasets using piroxicam as a model drug. The datasets represent two response surface designs for the capsule formulation which were developed to reflect the mapping from such variables as filler type/ratio, lubrication systems, drug particle size/specific surface area, disintegrants and surfactants to dissolution of the model compound. The capsules were filled using dosator-type automatic filling machines. Preliminary results indicate that the PEN is a working system. Good predictive power of the NN module requires sufficient training samples and a cross validation process. Further research will be directed toward: Validation and refinement of PEN Automation of the parameter adjustment as a process of optimization. Generalization of PEN to other drugs in BCS Class II. 1 S. Lai, F. Podcek, J.M. Newton, and R. Daumesnil. An expert system to aid the development of capsule formulations. Pharm. Tech. Eur., 8:60-65 (1996).